87 related articles for article (PubMed ID: 21739555)
21. Reassortment and modification of hemagglutinin cleavage motif of avian/WSN influenza viruses generated by reverse genetics that correlate with attenuation.
Lu JH; Long JX; Jia LJ; Liu YL; Shao WX; Zhang YM; Liu XF
Acta Virol; 2006; 50(4):243-9. PubMed ID: 17177609
[TBL] [Abstract][Full Text] [Related]
22. Immunization with influenza A NP-expressing vaccinia virus recombinant protects mice against experimental infection with human and avian influenza viruses.
Altstein AD; Gitelman AK; Smirnov YA; Piskareva LM; Zakharova LG; Pashvykina GV; Shmarov MM; Zhirnov OP; Varich NP; Ilyinskii PO; Shneider AM
Arch Virol; 2006 May; 151(5):921-31. PubMed ID: 16292596
[TBL] [Abstract][Full Text] [Related]
23. Rapid quantitation of neuraminidase inhibitor drug resistance in influenza virus quasispecies.
Lackenby A; Democratis J; Siqueira MM; Zambon MC
Antivir Ther; 2008; 13(6):809-20. PubMed ID: 18839782
[TBL] [Abstract][Full Text] [Related]
24. Comparative efficacy of North American and antigenically matched reverse genetics derived H5N9 DIVA marker vaccines against highly pathogenic Asian H5N1 avian influenza viruses in chickens.
Jadhao SJ; Lee CW; Sylte M; Suarez DL
Vaccine; 2009 Oct; 27(44):6247-60. PubMed ID: 19686695
[TBL] [Abstract][Full Text] [Related]
25. Temperature sensitivity on growth and/or replication of H1N1, H1N2 and H3N2 influenza A viruses isolated from pigs and birds in mammalian cells.
Massin P; Kuntz-Simon G; Barbezange C; Deblanc C; Oger A; Marquet-Blouin E; Bougeard S; van der Werf S; Jestin V
Vet Microbiol; 2010 May; 142(3-4):232-41. PubMed ID: 19926410
[TBL] [Abstract][Full Text] [Related]
26. H9N2 influenza A viruses from poultry in Asia have human virus-like receptor specificity.
Matrosovich MN; Krauss S; Webster RG
Virology; 2001 Mar; 281(2):156-62. PubMed ID: 11277689
[TBL] [Abstract][Full Text] [Related]
27. Analogue inhibitors by modifying oseltamivir based on the crystal neuraminidase structure for treating drug-resistant H5N1 virus.
Du QS; Wang SQ; Chou KC
Biochem Biophys Res Commun; 2007 Oct; 362(2):525-31. PubMed ID: 17707775
[TBL] [Abstract][Full Text] [Related]
28. Total synthesis of sialylated glycans related to avian and human influenza virus infection.
Hanashima S; Seeberger PH
Chem Asian J; 2007 Nov; 2(11):1447-59. PubMed ID: 17963282
[TBL] [Abstract][Full Text] [Related]
29. Contrasting substitution patterns between HA proteins of avian and human influenza viruses: Implication for monitoring human influenza epidemics.
Liao YC; Chen FC; Hsiung CA
Vaccine; 2010 Nov; 28(50):7890-6. PubMed ID: 20933040
[TBL] [Abstract][Full Text] [Related]
30. Variation in viral shedding patterns between different wild bird species infected experimentally with low-pathogenicity avian influenza viruses that originated from wild birds.
Costa TP; Brown JD; Howerth EW; Stallknecht DE
Avian Pathol; 2011 Apr; 40(2):119-24. PubMed ID: 21500030
[TBL] [Abstract][Full Text] [Related]
31. Structural and evolutionary characteristics of HA, NA, NS and M genes of clinical influenza A/H3N2 viruses passaged in human and canine cells.
Zhirnov OP; Vorobjeva IV; Saphonova OA; Poyarkov SV; Ovcharenko AV; Anhlan D; Malyshev NA
J Clin Virol; 2009 Aug; 45(4):322-33. PubMed ID: 19546028
[TBL] [Abstract][Full Text] [Related]
32. Avian influenza viruses and human health.
Alexander DJ
Dev Biol (Basel); 2006; 124():77-84. PubMed ID: 16447497
[TBL] [Abstract][Full Text] [Related]
33. An emerging avian influenza A virus H5N7 is a genetic reassortant of highly pathogenic genes.
Bragstad K; Jørgensen PH; Handberg KJ; Fomsgaard A
Vaccine; 2006 Nov; 24(44-46):6736-41. PubMed ID: 16814904
[TBL] [Abstract][Full Text] [Related]
34. Enzymological characteristics of avian influenza A virus neuraminidase.
Kiyotani K; Takei N; Senoo M; Takao S; Otsuki K; Tsubokura M; Yoshida T
Microbiol Immunol; 1987; 31(11):1131-5. PubMed ID: 2451112
[TBL] [Abstract][Full Text] [Related]
35. Substrate specificity of avian influenza H5N1 neuraminidase.
Onsirisakul N; Nakakita S; Boonarkart C; Kongchanagul A; Suptawiwat O; Puthavathana P; Chaichuen K; Kittiniyom K; Suzuki Y; Auewarakul P
World J Virol; 2014 Nov; 3(4):30-6. PubMed ID: 25396120
[TBL] [Abstract][Full Text] [Related]
36. Sialosides Containing 7-
Kooner AS; Yuan Y; Yu H; Kang H; Klenow L; Daniels R; Chen X
ACS Infect Dis; 2023 Jan; 9(1):33-41. PubMed ID: 36455156
[TBL] [Abstract][Full Text] [Related]
37. Rapid and specific influenza virus detection by functionalized magnetic nanoparticles and mass spectrometry.
Chou TC; Hsu W; Wang CH; Chen YJ; Fang JM
J Nanobiotechnology; 2011 Nov; 9():52. PubMed ID: 22088100
[TBL] [Abstract][Full Text] [Related]
38. Glyconanoparticles for the plasmonic detection and discrimination between human and avian influenza virus.
Marín MJ; Rashid A; Rejzek M; Fairhurst SA; Wharton SA; Martin SR; McCauley JW; Wileman T; Field RA; Russell DA
Org Biomol Chem; 2013 Nov; 11(41):7101-7. PubMed ID: 24057694
[TBL] [Abstract][Full Text] [Related]
39. Synthesis of novel N-acetylneuraminic acid derivatives as substrates for rapid detection of influenza virus neuraminidase.
Yang W; Liu X; Peng X; Li P; Wang T; Tai G; James Li X; Zhou Y
Carbohydr Res; 2012 Oct; 359():92-6. PubMed ID: 22925770
[TBL] [Abstract][Full Text] [Related]
40. Characterization of sialidase from an influenza A (H3N2) virus strain: kinetic parameters and substrate specificity.
França de Barros J; Sales Alviano D; da Silva MH; Dutra Wigg M; Sales Alviano C; Schauer R; dos Santos Silva Couceiro JN
Intervirology; 2003; 46(4):199-206. PubMed ID: 12931027
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
